In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22876-21-7, name is 5-Nitrobenzo[d]oxazole-2(3H)-thione, introducing its new discovery. Safety of 5-Nitrobenzo[d]oxazole-2(3H)-thione
Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist
We report a hit to lead study on a novel benzoxazole NPY Y5 antagonist. Starting from HTS hit 1, structure-activity relationships were developed. Compound 12 showed reduction of food intake and a tendency to suppress body weight gain over the 21-day experimental period.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22876-21-7, and how the biochemistry of the body works.Safety of 5-Nitrobenzo[d]oxazole-2(3H)-thione
Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem